WAJEEHA H RIZVI
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology QUINCY, IL NPI 1154773661
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology IL Incyte Corporation All categories
General Payments — all program years on this page
$1,942.35
- Category: General Payments
- Program years: PY2019–2024
- Record count: 82
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $847.23 across 40 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $797.24 | 39 |
| Education | $49.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $82.09 | 3 |
| Acerta Pharma LLC | $76.29 | 4 |
| Astellas Pharma US Inc | $73.05 | 3 |
| E.R. Squibb & Sons, L.L.C. | $68.73 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $52.60 | 3 |
| Daiichi Sankyo Inc. | $50.69 | 2 |
| GENZYME CORPORATION | $48.54 | 2 |
| Janssen Biotech, Inc. | $41.45 | 2 |
| Merck Sharp & Dohme Corporation | $38.62 | 2 |
| SOBI, INC | $32.41 | 2 |
| ABBVIE INC. | $28.66 | 1 |
| Regeneron Healthcare Solutions, Inc. | $28.32 | 1 |
| Grifols USA, LLC | $28.18 | 1 |
| Tempus AI, Inc | $24.68 | 1 |
| PFIZER INC. | $23.34 | 1 |
| Deciphera Pharmaceuticals Inc. | $21.70 | 1 |
| Exelixis Inc. | $20.38 | 1 |
| TerSera Therapeutics LLC | $20.04 | 1 |
| ARRAY BIOPHARMA INC | $15.50 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.25 | 1 |
| Celgene Corporation | $15.22 | 1 |
| Gilead Sciences, Inc. | $14.65 | 1 |
| Rigel Pharmaceuticals, Inc. | $13.54 | 1 |
| Genentech USA, Inc. | $13.30 | 1 |
By program year
Records — PY2024 (40)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.